Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2025-10-16 | 2026-01-08 | 269678 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110785 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2025-07-18 | 2025-08-29 | 263110 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-03-24 | 2022-04-21 | 157262 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2025-07-18 | 2025-08-29 | 263113 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2025-08-08 | 2025-09-02 | 264778 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2025-05-05 | 2025-09-02 | 256702 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2019-08-29 | 2020-01-30 | 92663 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-12-14 | 2024-06-13 | 213368 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258717 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| RATIO-LENOLTEC NO 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |